Related Experiment Video

Updated: Jun 22, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control

Camilla J Kobylecki1, Klaus D Jakobsen, Thomas Hansen

  • 1Research Institute of Biological Psychiatry, Copenhagen University Hospital, Sct. Hans Hospital, Roskilde, Denmark.

Neuropsychobiology
|June 13, 2009
PubMed
Abstract

Insights

Patients with the CYP2D6 poor metabolizer genotype taking antipsychotics experienced more side effects like EPS/TD. This suggests genetic screening could improve treatment outcomes by predicting adverse drug reactions.

Area of Science:

  • Pharmacogenomics
  • Clinical Psychiatry

Background:

  • The cytochrome P450 (CYP) enzyme CYP2D6 plays a crucial role in metabolizing many antipsychotic medications.
  • Individuals with the CYP2D6 poor metabolizer (PM) genotype exhibit reduced drug metabolism, potentially leading to higher plasma concentrations and increased risk of adverse effects.

Purpose of the Study:

  • To investigate the clinical impact of the CYP2D6 poor metabolizer genotype on antipsychotic treatment outcomes.
  • To determine if CYP2D6 genotype is associated with increased risk of side effects in patients with schizophrenia spectrum disorders.

Main Methods:

  • A retrospective pilot study matched 18 CYP2D6 PM patients with schizophrenia spectrum diagnoses to intermediate metabolizer (IM) and extensive metabolizer (EM) controls.
  • Clinical data, focusing on treatment side effects, were extracted from medical records by a blinded psychiatrist.

Main Results:

  • CYP2D6 PM patients showed a significantly higher incidence of extrapyramidal syndrome or tardive dyskinesia (EPS/TD) compared to matched IM and EM controls.
  • A higher prevalence of noncompliance was observed in PM patients, potentially linked to increased side effects.
  • These associations were independent of the use of CYP2D6-dependent or EPS/TD-causing medications.

Conclusions:

  • Genetically determined differences in CYP2D6 metabolism can predict antipsychotic-related side effects.
  • Early pharmacogenetic screening for CYP2D6 genotype may facilitate personalized pharmacotherapy adjustments, potentially improving treatment outcomes and reducing adverse events.

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...